EUVIMEDEUVIMED entdecken
Vergleichsstudie

Prognostic Differences Among T3 Descriptor Subgroups in Resected Lung Cancer

Canberk Heskiloğlu, Necati Citak, Serkan Yazgan, Ahmet Üçvet, Kenan C Ceylan

The Thoracic and Cardiovascular Surgeon · 01.09.2026 · 74 (06) · 503-509

DOI: 10.1055/a-2722-4702 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.09.2026. Verfasst von Canberk Heskiloğlu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Doctor Suat Seren Chest Diseases Training and Research Hospital, Izmir, Konak, Turkey. Hauptthemen laut MEDLINE: Lung Neoplasms, Pneumonectomy, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prognostic heterogeneity may exist among T3 nonsmall cell lung cancers depending on specific T3 descriptors. Our study aimed to evaluate the survival differences among T3 subgroups in patients with resected lung cancer. This retrospective cohort study included 381 patients with pathologically confirmed (p)T3N0/1 nonsmall cell lung cancer. Patients with mediastinal lymph node metastases or superior sulcus tumors were excluded. Patients were classified into three subgroups; the T3-ordinary group (only tumor diameter >5 cm but ≤7 cm, or only an additional tumor nodule in the same lobe as the primary tumor, n = 246), the T3-invasion group (the primary tumor directly invades any of the structures; only the phernic nerve, pericardium, parietal pleura or the chest wall, n = 57), and the T3-multiple group (the tumor had at least two T3 descriptors, n = 78). The 5-year overall survival rate was 52% (median survival time: 63 months; 95% CI: 53–72 months). A significant difference was observed between the three groups in terms of median survival time (T3-ordinary, 70 months; T3-invasion, 58 months; T3-multiple, 43 months; chi-square = 5.86, p = 0.04-log rank). Moreover, the 5-year survival rate was significantly higher in the T3 single group than in the T3 multiple group (54.5% vs. 40.4%, p = 0.03). Multivariate analysis showed that lymph node status (p = 0.007), adjuvant treatment (p < 0.001), major surgical complications (p < 0.001), and T3-subgroups (p = 0.02) were independent prognostic factors. Patients with two or more pT3 descriptors or tumors exhibiting invasion have the worst survival rates. Stage migration can be discussed in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPneumonectomyCarcinoma, Non-Small-Cell LungHumansRetrospective StudiesFemaleNeoplasm StagingMaleNeoplasm InvasivenessTime FactorsTreatment OutcomeMiddle AgedAgedRisk FactorsKaplan-Meier EstimateLymphatic MetastasisChi-Square DistributionTumor BurdenAged, 80 and over

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Doctor Suat Seren Chest Diseases Training and Research Hospital, Izmir, Konak, Turkey.

Zitieren

APA

Heskiloğlu, C., Citak, N., Yazgan, S., Üçvet, A., & Ceylan, K. C. (2026). Prognostic Differences Among T3 Descriptor Subgroups in Resected Lung Cancer. The Thoracic and Cardiovascular Surgeon, 74(06), 503-509. https://doi.org/10.1055/a-2722-4702

Vancouver

Heskiloğlu C, Citak N, Yazgan S, Üçvet A, Ceylan KC. Prognostic Differences Among T3 Descriptor Subgroups in Resected Lung Cancer. The Thoracic and Cardiovascular Surgeon. 2026;74(06):503-509. doi:10.1055/a-2722-4702

BibTeX
@article{Heskilolu2026,
  author = {Heskiloğlu, Canberk and Citak, Necati and Yazgan, Serkan and Üçvet, Ahmet and Ceylan, Kenan C},
  title = {Prognostic Differences Among T3 Descriptor Subgroups in Resected Lung Cancer},
  journal = {The Thoracic and Cardiovascular Surgeon},
  year = {2026},
  volume = {74},
  number = {06},
  pages = {503--509},
  doi = {10.1055/a-2722-4702}
}
Kostenlos starten →